1. Home
  2. KE vs LXRX Comparison

KE vs LXRX Comparison

Compare KE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.56

Market Cap

635.4M

Sector

Technology

ML Signal

HOLD

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$2.24

Market Cap

703.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
LXRX
Founded
1961
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
635.4M
703.3M
IPO Year
2014
2000

Fundamental Metrics

Financial Performance
Metric
KE
LXRX
Price
$24.56
$2.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$28.00
$4.15
AVG Volume (30 Days)
123.8K
2.9M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
77.78
EPS
0.78
N/A
Revenue
$1,486,727,000.00
$49,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$32.10
N/A
Revenue Growth
N/A
60.24
52 Week Low
$17.17
$0.52
52 Week High
$33.19
$2.53

Technical Indicators

Market Signals
Indicator
KE
LXRX
Relative Strength Index (RSI) 39.95 65.84
Support Level $23.49 $1.44
Resistance Level $26.92 N/A
Average True Range (ATR) 1.18 0.16
MACD -0.31 0.07
Stochastic Oscillator 11.98 71.78

Price Performance

Historical Comparison
KE
LXRX

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: